Negative regulatory role of overexpression of PLC gamma 1 in the expression of early growth response 1 gene in rat 3Y1 fibroblasts

FASEB J. 2002 Oct;16(12):1504-14. doi: 10.1096/fj.02-0022com.

Abstract

The early growth response 1 (Egr-1) gene product is a transcription factor that functions as an oikis factor. Loss of Egr-1 expression is closely associated with tumor formation. Phospholipase Cgamma1 (PLCgamma1) is overexpressed in some tumors, and its overexpression causes anchorage-independent growth. Here we report that overexpression of PLCgamma1 and SH2-SH3 domain of PLCgamma1 decreased induction of Egr-1 and the Egr-1-regulated genes TSP-1 and PAI-1. Results from the nuclear run-on assay and transfection experiment with the proximal 455 base pair region of the Egr-1 promoter (-454 to +1) showed that Egr-1 transcriptional activity was suppressed in PLCgamma1-3Y1 cells whereas decay of Egr-1 mRNA was similar in both cell lines. Serum response element- and ternary complex factor Elk-1-mediated transcriptional activation of the reporter gene in response to EGF were also inhibited in PLCgamma1-3Y1 cells. Pretreatment with the protein synthesis inhibitor cycloheximide (CHX) partially abrogated the serum-induced suppression of Egr-1 transcription in PLCgamma1-3Y1 cells, suggesting that a CHX-sensitive factor(s) is involved in the suppression of Egr-1 transcription in PLCgamma1-3Y1 cells. Our results demonstrated that overexpression of PLCgamma1 functions as a negative modulator of the tumor suppressor Egr-1 gene expression, possibly through inhibition of Elk-1-dependent transcriptional activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Culture Media, Serum-Free / pharmacology
  • Cycloheximide / pharmacology
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Dactinomycin / pharmacology
  • Early Growth Response Protein 1
  • Epidermal Growth Factor / pharmacology
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Gene Expression Regulation / drug effects
  • Humans
  • Immediate-Early Proteins*
  • Isoenzymes / genetics
  • Isoenzymes / metabolism*
  • Isoenzymes / physiology
  • Phospholipase C gamma
  • Plasmids / genetics
  • Promoter Regions, Genetic / genetics
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / physiology
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*
  • Transcriptional Activation
  • Tumor Cells, Cultured
  • Type C Phospholipases / genetics
  • Type C Phospholipases / metabolism*
  • Type C Phospholipases / physiology
  • ets-Domain Protein Elk-1
  • src Homology Domains / genetics

Substances

  • Culture Media, Serum-Free
  • DNA-Binding Proteins
  • EGR1 protein, human
  • ELK1 protein, human
  • Early Growth Response Protein 1
  • Egr1 protein, rat
  • Elk1 protein, rat
  • Immediate-Early Proteins
  • Isoenzymes
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Transcription Factors
  • ets-Domain Protein Elk-1
  • Dactinomycin
  • Epidermal Growth Factor
  • Cycloheximide
  • Type C Phospholipases
  • Phospholipase C gamma